eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.

  • Lise Boussemart
  • , Hélène Malka-Mahieu
  • , Isabelle Girault
  • , Delphine Allard
  • , Oskar Hemmingsson
  • , Gorana Tomasic
  • , Marina Thomas
  • , Christine Basmadjian
  • , Nigel Ribeiro
  • , Frédéric Thuaud
  • , Christina Mateus
  • , Emilie Routier
  • , Nyam Kamsu-Kom
  • , Sandrine Agoussi
  • , Alexander M. Eggermont
  • , Laurent Désaubry
  • , Caroline Robert
  • , Stéphan Vagner

Research output: Contribution to journal › Article › peer-review

297 Citations (Scopus)

Fingerprint

Dive into the research topics of 'eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science